|
1
|
Wei J and Wu J, Xu W, Nie H, Zhou R, Wang
R, Liu Y, Tang G and Wu J: Salvanic acid B inhibits glycolysis in
oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1α
signaling pathway. Cell Death Dis. 9:5992018. View Article : Google Scholar
|
|
2
|
Montler R, Bell RB, Thalhofer C, Leidner
R, Feng Z, Fox BA, Cheng AC, Bui TG, Tucker C, Hoen H and Weinberg
A: OX40, PD-1 and CTLA-4 are selectively expressed on
tumor-infiltrating T cells in head and neck cancer. Clin Transl
Immunology. 5:e702016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta B, Bray F, Kumar N and Johnson NW:
Associations between oral hygiene habits, diet, tobacco and alcohol
and risk of oral cancer: A case-control study from India. Cancer
Epidemiol. 51:7–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sajan T, Murthy S, Krishnankutty R and
Mitra J: A rapid, early detection of oral squamous cell carcinoma:
Real time PCR based detection of tetranectin. Mol Biol Res Commun.
8:33–40. 2019.PubMed/NCBI
|
|
5
|
Kim SM, Jeong D, Kim MK, Lee SS and Lee
SK: Two different protein expression profiles of oral squamous cell
carcinoma analyzed by immunoprecpitation high performance liquid
chro-matog raphy. World J Surg Oncol. 15:1512017. View Article : Google Scholar
|
|
6
|
Radhika T, Jeddy N, Nithya S and
Muthumeenakshi RM: Salivary biomarkers in oral squamous cell
carcinoma-an insight. J Oral Biol Craniofac Res. 6(Suppl 1):
S51–S54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sasahira T, Kirita T and Kuniyasu H:
Update of molecular patho-biology in oral cancer: A review. Int J
Clin Oncol. 19:431–436. 2014. View Article : Google Scholar
|
|
8
|
Mk H, Prince S, Mohan AM, Krishnan KV and
Devi A: Association of Notch4 with metastasis in human oral
squamous cell carcinoma. Life Sci. 156:38–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dai BW, Yang ZM, Deng P, Chen YR, He ZJ,
Yang X, Zhang S, Wu HJ and Ren ZH: HOXC10 promotes migration and
invasion via the WNT-EMT signaling pathway in oral squamous cell
carcinoma. J Cancer. 10:4540–4551. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma H, Li L, Jia L, Gong A, Wang A, Zhang
L, Gu M and Tang G: POM121 is identified as a novel prognostic
marker of oral squamous cell carcinoma. J Cancer. 10:4473–4480.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao W, Zhu H, Zhang S, Yong H, Wang W,
Zhou Y, Wang B, Wen J, Qiu Z, Ding G, et al: Trop2 is overexpressed
in gastric cancer and predicts poor prognosis. Oncotarget.
7:6136–6145. 2016.
|
|
12
|
Lin H, Zhang H, Wang J, Lu M, Zheng F,
Wang C, Tang X, Xu N, Chen R, Zhang D, et al: A novel human Fab
antibody for Trop2 inhibits breast cancer growth in vitro and in
vivo. Int J Cancer. 134:1239–1249. 2014. View Article : Google Scholar
|
|
13
|
Fang YJ, Lu ZH, Wang GQ, Pan ZZ, Zhou ZW,
Yun JP, Zhang MF and Wan DS: Elevated expressions of MMP7, TROP2,
and survivin are associated with survival, disease recurrence, and
liver metastasis of colon cancer. Int J Colorectal Dis. 24:875–884.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cubas R, Zhang S, Li M, Chen C and Yao Q:
Trop2 expression contributes to tumor pathogenesis by activating
the ERK MAPK pathway. Mol Cancer. 9:2532010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mao Y, Wang X, Zheng F, Wang C, Tang Q,
Tang X, Xu N, Zhang H, Zhang D, Xiong L, et al: The
tumor-inhibitory effectiveness of a novel anti-Trop2 Fab conjugate
in pancreatic cancer. Oncotarget. 7:24810–24823. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fong D, Moser P, Krammel C, Gostner JM,
Margreiter R, Mitterer M, Gastl G and Spizzo G: High expression of
TROP2 correlates with poor prognosis in pancreatic cancer. Br J
Cancer. 99:1290–1295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goldstein AS, Huang J, Guo C, Garraway IP
and Witte ON: Identification of a cell of origin for human prostate
cancer. Science. 329:568–571. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang XD, Wang Q, Chen XL, Huang JF, Yin Y,
Da P and Wu H: Trop2 inhibition suppresses the proliferation and
invasion of laryngeal carcinoma cells via the extracellular
signal-regulated kinase/mitogen-activated protein kinase pathway.
Mol Med Rep. 12:865–870. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang G, Tang Q, Jia L, Xia S, Li J, Chen
Y, Li H, Ding X, Wang F, Hou D, et al: High expression of TROP2 is
correlated with poor prognosis of oral squamous cell carcinoma.
Pathol Res Pract. 214:1606–1612. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Workman P, Aboagye EO, Balkwill F, Balmain
A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA,
Glennie MJ, et al: Guidelines for the welfare and use of animals in
cancer research. Br J Cancer. 102:1555–1577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Zhao W, Kuai X, Zhou X, Jia L, Wang J,
Yang X, Tian Z, Wang X, Lv Q, Wang B, et al: Trop2 is a potential
biomarker for the promotion of EMT in human breast cancer. Oncol
Rep. 40:759–766. 2018.PubMed/NCBI
|
|
23
|
Hashmi AA, Ali R, Hussain ZF, Faridi N,
Khan EY, Bakar SMA, Edhi MM and Khan M: Mismatch repair deficiency
screening in colorectal carcinoma by a four-antibody
immunohistochemical panel in Pakistani population and its
correlation with histopathological parameters. World J Surg Oncol.
15:1162017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gu QZ, Nijiati A, Gao X, Tao KL, Li CD,
Fan XP and Tian Z: TROP2 promotes cell proliferation and migration
in osteosarcoma through PI3K/AKT signaling. Mol Med Rep.
18:1782–1788. 2018.PubMed/NCBI
|
|
25
|
Li X, Teng S, Zhang Y, Zhang W, Zhang X,
Xu K, Yao H, Yao J, Wang H, Liang X and Hu Z: TROP2 promotes
proliferation, migration and metastasis of gallbladder cancer cells
by regulating PI3K/AKT pathway and inducing EMT. Oncotarget.
8:47052–47063. 2017.PubMed/NCBI
|
|
26
|
Kong XP, Yao J, Luo W, Feng FK, Ma JT, Ren
YP, Wang DL and Bu RF: The expression and functional role of a
FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma. Mol
Cell Biochem. 394:177–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia X, Du R, Zhao L, Sun W and Wang X:
Expression of AEG-1 and microvessel density correlates with
metastasis and prognosis of oral squamous cell carcinoma. Hum
Pathol. 45:858–865. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen CJ, Hsu LS, Lin SH, Chen MK, Wang HK,
Hsu JD, Lee H and Yeh KT: Loss of nuclear expression of
Krüppel-like factor 4 is associated with poor prognosis in patients
with oral cancer. Hum Pathol. 43:1119–1125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Imani R, Seyedmajidi M, Ghasemi N, Moslemi
D, Shafaee S and Bijani A: HLA-G expression is associated with an
unfavorable prognosis of oral squamous cell carcinoma. Asian Pac J
Cancer Prev. 19:2527–2533. 2018.PubMed/NCBI
|
|
30
|
Zhao W, Jia L, Kuai X, Tang Q, Huang X,
Yang T, Qiu Z, Zhu J, Huang J, Huang W and Feng Z: The role and
molecular mechanism of Trop2 induced epithelial-mesenchymal
transition through mediated β-catenin in gastric cancer. Cancer
Med. 8:1135–1147. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wanger TM, Dewitt S, Collins A, Maitland
NJ, Poghosyan Z and Knauper V: Differential regulation of TROP2
release by PKC isoforms through vesicles and ADAM17. Cell Signal.
27:1325–1335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cubas R, Li M, Chen C and Yao Q: Trop2: A
possible therapeutic target for late stage epithelial carcinomas.
Biochim Biophys Acta. 1796:309–314. 2009.PubMed/NCBI
|
|
33
|
Ersahin T, Tuncbag N and Cetin-Atalay R:
The PI3K/AKT/mTOR interactive pathway. Mol Biosyst. 11:1946–1954.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lim HJ, Crowe P and Yang JL: Current
clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment
of human cancer. J Cancer Res Clin Oncol. 141:671–689. 2015.
View Article : Google Scholar
|
|
35
|
Carnero A, Blanco-Aparicio C, Renner O,
Link W and Leal JF: The PTEN/PI3K/AKT signalling pathway in cancer,
therapeutic implications. Curr Cancer Drug Targets. 8:187–198.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ju X, Jiao X, Ertel A, Casimiro MC, Di
Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, et al: v-Src
oncogene induces Trop2 proteolytic activation via cyclin D1. Cancer
Res. 76:6723–6734. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Z, Jiang X and Zhang W: TROP2
overexpression promotes proliferation and invasion of lung
adenocarcinoma cells. Biochem Biophys Res Commun. 470:197–204.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu X, Li S and Yi F: Trop2 gene: A novel
target for cervical cancer treatment. J Cancer Res Clin Oncol.
140:1331–1341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Salmena L, Carracedo A and Pandolfi PP:
Tenets of PTEN tumor suppression. Cell. 133:403–414. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang Y, Zhang R, Luo G and Ai K: Long
noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT
signaling pathway in pancreatic ductal adenocarcinoma. J Cancer.
9:2713–2722. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Correction: PI3K inhibition reduces
mammary tumor growth and facilitates antitumor immunity and
anti-PD1 responses. Clin Cancer Res. 24:37822018. View Article : Google Scholar
|
|
42
|
Zhang XR, Wang SY, Sun W and Wei C:
Isoliquiritigenin inhibits proliferation and metastasis of MKN28
gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling
pathway. Mol Med Rep. 18:3429–3436. 2018.PubMed/NCBI
|
|
43
|
Wise HM, Hermida MA and Leslie NR:
Prostate cancer, PI3K, PTEN and prognosis. Clin Sci (Lond).
131:197–210. 2017. View Article : Google Scholar
|
|
44
|
Yuan B, Zou M, Zhao Y, Zhang K, Sun Y and
Peng X: Up-regulation of miR-130b-3p activates the
PTEN/PI3K/AKT/NF-κB pathway to defense against mycoplasma
gallisepticum (HS Strain) infection of chicken. Int J Mol Sci.
19:E21722018. View Article : Google Scholar
|
|
45
|
Li JW, Wang XY, Zhang X, Gao L, Wang LF
and Yin XH: (-)-Epicatechin protects against myocardial
ischemiainduced cardiac injury via activation of the PTEN/PI3K/AKT
pathway. Mol Med Rep. 17:8300–8308. 2018.PubMed/NCBI
|
|
46
|
Yoshizaki H, Mochizuki N, Gotoh Y and
Matsuda M: Akt-PDK1 complex mediates epidermal growth
factor-induced membrane protrusion through Ral activation. Mol Biol
Cell. 18:119–128. 2007. View Article : Google Scholar :
|
|
47
|
Vander Broek R, Mohan S, Eytan DF, Chen Z
and Van Waes C: The PI3K/Akt /mTOR axis in head and neck cancer:
Functions, aberrations, cross-talk, and therapies. Oral Dis.
21:815–825. 2015. View Article : Google Scholar
|
|
48
|
Feng Q, Di R, Tao F, Chang Z, Lu S, Fan W,
Shan C, Li X and Yang Z: PDK1 regulates vascular remodeling and
promotes epithelial-mesenchymal transition in cardiac development.
Mol Cell Biol. 30:3711–3721. 2010. View Article : Google Scholar : PubMed/NCBI
|
